File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S0140-6736(17)31046-2
- Scopus: eid_2-s2.0-85018660134
- PMID: 28434648
- WOS: WOS:000403901800028
Supplementary
- Citations:
- Appears in Collections:
Article: Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Title | Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial |
---|---|
Authors | |
Issue Date | 2017 |
Citation | Lancet, 2017, v. 389, p. 2492-2502 How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/249664 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | El-Khoueiry, AB | - |
dc.contributor.author | Sangro, B | - |
dc.contributor.author | Yau, TCC | - |
dc.contributor.author | Crocenzi, TS | - |
dc.contributor.author | Kudo, M | - |
dc.contributor.author | Hsu, C | - |
dc.contributor.author | Kim, TY | - |
dc.contributor.author | Choo, SP | - |
dc.contributor.author | Trojan, J | - |
dc.contributor.author | Welling, TH | - |
dc.contributor.author | Meyer, T | - |
dc.contributor.author | Kang, YK | - |
dc.contributor.author | Yeo, W | - |
dc.contributor.author | Chopra, A | - |
dc.contributor.author | Anderson, J | - |
dc.contributor.author | Dela Cruz, C | - |
dc.contributor.author | Lang, L | - |
dc.contributor.author | Neely, J | - |
dc.contributor.author | Tang, H | - |
dc.contributor.author | Dastani, HB | - |
dc.contributor.author | Melero, I | - |
dc.date.accessioned | 2017-11-21T03:05:18Z | - |
dc.date.available | 2017-11-21T03:05:18Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | Lancet, 2017, v. 389, p. 2492-2502 | - |
dc.identifier.uri | http://hdl.handle.net/10722/249664 | - |
dc.language | eng | - |
dc.relation.ispartof | Lancet | - |
dc.title | Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial | - |
dc.type | Article | - |
dc.identifier.email | Yau, TCC: tyaucc@hku.hk | - |
dc.identifier.authority | Yau, TCC=rp01466 | - |
dc.identifier.doi | 10.1016/S0140-6736(17)31046-2 | - |
dc.identifier.pmid | 28434648 | - |
dc.identifier.scopus | eid_2-s2.0-85018660134 | - |
dc.identifier.hkuros | 283251 | - |
dc.identifier.volume | 389 | - |
dc.identifier.spage | 2492 | - |
dc.identifier.epage | 2502 | - |
dc.identifier.isi | WOS:000403901800028 | - |